Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/43837
Title: Early liver function improvement following successful treatment of chronic hepatitis C in patients with decompensated cirrhosis: a real-life study
Authors: LOURENCO, Mariana SandovalZITELLI, Patricia Momoyo Y.CUNHA-SILVA, MarloneOLIVEIRA, Arthur Ivan N.LIMA, Roque Gabriel Rezende deOLIVEIRA, Souza Evandro deOLIVEIRA, Claudia P.SEVA-PEREIRA, TiagoCARRILHO, Flair J.PESSOA, Mario G.MAZO, Daniel F.
Citation: CLINICS, v.76, article ID e3186, 8p, 2021
Abstract: OBJECTIVES: Despite higher rates of sustained virologic response (SVR), important concerns remain when patients with decompensated cirrhosis due to hepatitis C virus (HCV) are treated with direct-acting antiviral agents (DAA). Questions include efficacy, safety, and the magnitude of liver function improvement. Here, we aimed to evaluate HCV treatment data in this specific population in Brazil. METHODS: We included 85 patients with decompensated cirrhosis submitted to HCV therapy with DAA followed at two academic tertiary centers in the southeastern region of Brazil. RESULTS: Seventy-nine patients (92.9%) were Child-Pugh (CP) score B, and six (7.1%) were CP score C. The mean MELD score was 12.86. The most common treatment was sofosbuvir plus daclatasvir +/- ribavirin for 24 weeks. The overall intention-to-treat (ITT) SVR rate was 87.4% (74/85) and modified-ITT 96.1% (74/77). ITT SVR was associated with lower baseline INR values (p.=0.029). Adverse events (AE) occurred in 57.9% (44/76) of patients. Serious AE were reported in 12.8% (10/78), and were related to the presence of hepatic encephalopathy (p.=0.027). SVR was associated with improvement in CP (p<0.0001) and MELD scores (p.=0.021). Among baseline CP score B patients with SVR, 46% (29/63) regressed to CP score A. Ascites was independently associated with no improvement in liver function in patients who achieved SVR (p.=0.001; OR:39.285; 95% CI:4.301-258.832). CONCLUSIONS: Patients with decompensated HCV cirrhosis showed a high SVR rate with interferon-free therapy. Early liver function improvement occurred after successful HCV eradication. However, long-term follow-up of these patients after SVR remains strongly advised.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MGT
Departamento de Gastroenterologia - FM/MGT

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/07
LIM/07 - Laboratório de Gastroenterologia Clínica e Experimental


Files in This Item:
File Description SizeFormat 
art_LOURENCO_Early_liver_function_improvement_following_successful_treatment_of_2021.PDFpublishedVersion (English)648.02 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.